top of page
Search
  • habcfoundationuk
    • Oct 15, 2021
    • 1 min read

New Biotech, Synaptix, launched to develop treatment for Tubb4a H-abc!

Very exciting news for the H-abc community. Biotech Synaptix has launched and are working hard to develop ASO gene therapy for H-abc and Tubb4a. Click on their website below to learn more.

www.synaptixbio.com



30 views0 comments
bottom of page